November 8, 2022
DeepHealth RSNA 2022

At the 2022 annual meeting of the Radiology Society of North America (RSNA), members of Dr. Sorensen’s DeepHealth team have been invited to take center stage in several different sessions to present cutting edge research regarding AI in breast imaging. Greg Sorensen, M.D., Chief Executive Officer and co-founder of Deep Health, and head of the artificial intelligence (AI) division of RadNet, has been recently featured by RSNA to celebrate his contributions to the field of imaging and to recognize the impact of RSNA Research and Education (R&E) Foundation grants on his work.

Dr. Sorensen received two funding opportunities from the R&E Foundation early in his career, which were pivotal for his non-traditional path. The RSNA Research Resident Grant in 1993 and the Bracco Diagnostics/RSNA Research Scholar Grant in 1995 helped him pursue academic neuroradiology for almost two decades, during which time he was a professor at Harvard University. Dr. Sorensen then transitioned to the business of imaging, where he is able to bring AI innovations to the marketplace. “Now my opportunities for having an impact on patient care are even greater,” he said.

At RSNA 2022, the team will present several featured papers relating to the use of AI in breast cancer screening. Of particular interest is the scientific paper, Racial Disparities in Proportion of Patients Returning for Annual Screening Mammograms, which will focus on the disparity in cancer incidence and mortality among different races and how adherence to mammography screening guidelines plays a role in that disparity. AI holds the potential to expand access to high-quality care. ”Deep learning-based AI software has shown to boost the quality of interpretations markedly, and it brings the performance of generalists to at, or above that, of specialists,” he said. “This is great news for patients, who will be able to receive improved access and quality.”

Dr. Sorensen cites the R&E Foundation as an integral part of his evolution as a care provider. “These funding opportunities had a transformative effect on my career. That support is what has enabled me to have a positive, concrete role in healthcare today.”